Perspective Perspectives are commissioned from an expert and discuss the clinical practice or public health implications of a published study. The original publication must be freely available online.

See all article types »

Is DOTS-Plus a Feasible and Cost-Effective Strategy?

  • Paul Garner mail,

    To whom correspondence should be addressed. E-mail:

  • Marissa Alejandria,
  • Mary Ann Lansang
  • Published: September 12, 2006
  • DOI: 10.1371/journal.pmed.0030350

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.

Linked Articles

Feasibility and Cost-Effectiveness of Treating Multidrug-Resistant Tuberculosis: A Cohort Study in the Philippines

Thelma E Tupasi, Rajesh Gupta, Ma Imelda D Quelapio, Ruth B Orillaza, Nona Rachel Mira, Nellie V Mangubat, Virgil Belen, Nida Arnisto, Lualhati Macalintal, Michael Arabit, Jaime Y Lagahid, ...
Research Article | published 12 Sep 2006 | PLOS Medicine